A15.8
Other respiratory tuberculosis
Clinical Classification Guidelines
Inclusion Terms
- Mediastinal tuberculosis
- Nasopharyngeal tuberculosis
- Tuberculosis of nose
- Tuberculosis of sinus [any nasal]
Medical Intelligence & Overview
Other respiratory tuberculosis, classified under ICD-10 code A15.8, encompasses various forms of tuberculosis that affect the respiratory system but do not fall into the more common categories such as pulmonary tuberculosis. This includes infections of the mediastinum, nasopharynx, nose, and sinuses. These conditions are caused by the bacteria Mycobacterium tuberculosis, which primarily spreads through airborne droplets released when an infected person coughs, sneezes, or talks. Recognizing and understanding these less common forms of tuberculosis is crucial for early diagnosis and management, especially in individuals with weakened immune systems or those living in areas with higher TB prevalence.
Causes & Symptoms
Clinical Causes: Inhalation of airborne droplets containing Mycobacterium tuberculosis Close contact with infected individuals Pre-existing lung diseases that allow bacteria to spread to other respiratory areas Immunocompromised states, such as HIV infection or chemotherapy Travel or residence in regions with high TB rates
Key Symptoms: Persistent nasal congestion or obstruction Nasal or sinus pain and swelling Nasal discharge, which may be bloody Swelling or lumps in the neck (due to lymph node involvement) Chronic cough or sore throat if the upper airway is affected Unexplained weight loss and fatigue Fever, night sweats, and general malaise Difficulty breathing or facial deformities in advanced cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation, imaging studies such as X-rays or CT scans, and laboratory tests. These may include:
Treatment Protocols: Treatment generally involves a prolonged course of multi-drug anti-tubercular therapy, which may include medications such as isoniazid, rifampin, ethambutol, and pyrazinamide. The duration of treatment typically ranges from 6 to 12 months, depending on the severity and location of the infection. Additional supportive measures might include:
Clinical Advice & FAQs
Billing Guidance
Is A15.8 a billable ICD-10 code?
Yes, A15.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A15.8?
Clinical documentation must specify the nature of Other respiratory tuberculosis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference